A wave of notices from the regulator
The Food Safety and Standards Authority of India, known as FSSAI, said on Wednesday that it had issued notices over products including the Complan children’s drink, Lactogen Pro 1 Powder, NAN Excella Pro Stage 1 and other infant milk substitutes. The regulator said the promotional claims linked to these products breached its rules on how foods for infants and children can be marketed.
The action reflects growing concern in India about how nutrition products are sold to parents, who often trust health messages printed on packages or shared online. Products for babies and young children are among the most sensitive categories in the food industry, because early nutrition shapes long-term health and because parents are especially receptive to promises of better growth and immunity.
Claims under the spotlight
The notices focus on specific promises that the regulator wants companies to prove with evidence:
- Nestle India was asked to provide evidence supporting claims about digestive and immune-system benefits for its Lactogen Pro 1 Powder and NAN Excella Pro Stage 1 infant formula products.
- Zydus Wellness was asked to provide scientific justification for claims promoting Complan, including the tagline “grow taller, faster. clinically proven 2X growth.”

















